Clincosm LogoSign in Get a demo

Chronic Lymphocytic Leukemia (CLL)

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

Recruiting
  • Multiple Myeloma (MM)
  • +5 more
  • Santander, Cantabria, Spain
  • +4 more
Jun 19, 2023

Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2023

    Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

    Recruiting
    • Relapsed or Refractory B-cell Lymphoma
    • +6 more
    • Beijing, China
      Beijing Cancer Hospital
    Feb 6, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Aurora, Colorado
    • +55 more
    Jan 30, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • Nagoya-shi, Aichi, Japan
    • +19 more
    Jan 25, 2023

    Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Waldenstrom Macroglobulinemia (WM)
    • Shingrix vaccine
    • Rochester, New York
      University of Rochester
    Jan 9, 2023

    Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Basking Ridge, New Jersey
    • +6 more
    Jan 3, 2023

    Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Stamford, Connecticut
    • +4 more
    Dec 2, 2022

    Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

    Recruiting
    • Mantle Cell Lymphoma
    • +9 more
    • L-Bcl-2 antisense oligonucleotide
    • Augusta, Georgia
    • +2 more
    Nov 18, 2022

    Venclexta in Relapse or Refractory Chronic Lymphocytic Leukemia

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
    • Cancer
    • Sochi, Krasnodarskiy Kray, Russian Federation
    • +19 more
    Oct 6, 2022

    Venetoclax Treatment in Chronic Lymphocytic Leukemia Routine

    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
      • Be'er Sheva, HaDarom, Israel
      • +12 more
      Sep 9, 2022

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Leukemia (SLL)
      • Evanston, Illinois
      • +7 more
      Sep 9, 2022

      Hairy Cell and Other Leukemias, and to Develop Recombinant

      Recruiting
      • Hairy Cell Leukemia (HCL)
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • +7 more
        • Manchester, United Kingdom
        • +2 more
        Aug 11, 2022

        Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL) Trial in United States (voruciclib

        Recruiting
        • Follicular Lymphoma (FL)
        • +6 more
        • voruciclib monotherapy
        • voruciclib and venetoclax
        • Duarte, California
        • +10 more
        Aug 10, 2022

        Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • La Jolla, California
        • +41 more
        Aug 10, 2022

        Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

        Recruiting
        • Relapsed/Refractory B-cell Lymphomas
        • +11 more
        • CLBR001 and SWI019
        • Duarte, California
        • +7 more
        Jul 26, 2022

        Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM) Trial in United States

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • +6 more
        • Duarte, California
        • +10 more
        Jul 14, 2022

        Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

        Recruiting
        • Non-Hodgkin's Lymphoma (NHL)
        • +4 more
        • Indianapolis, Indiana
        • +1 more
        Jul 12, 2022

        Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

        Recruiting
        • Non Hodgkin Lymphoma (NHL)
        • +6 more
        • 8/12-Day Production of Car-T Cells
        • +2 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin and Froedtert Hospital
        Jul 1, 2022

        Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        May 13, 2022

        MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

        Recruiting
        • Monoclonal Gammopathy of Undetermined Significance (MGUS)
        • +8 more
          • Boston, Massachusetts
          • +6 more
          Apr 14, 2022

          Chronic Lymphocytic Leukemia (CLL) Trial

          Completed
          • Chronic Lymphocytic Leukemia (CLL)
            • (no location specified)
            Apr 5, 2022